Irtemazole

Irtemazole

SCHEMBL636285

Cc1nc2ccc(C(c3ccccc3)n3ccnc3)cc2[nH]1

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP26A1 O43174 6/20 0.57
CYP19A1 P11511 10/20 0.57
CYP17A1 P05093 2/20 0.54
CYP3A4 P08684 2/20 0.54
MEN1 O00255 1/20 0.54
NR1I2 O75469 1/20 0.54
USP2 O75604 1/20 0.54
ABCB11 O95342 1/20 0.54
ALDH1A1 P00352 1/20 0.54
PLA2G1B P04054 1/20 0.54
TP53 P04637 1/20 0.54
PGR P06401 1/20 0.54
HSP90AA1 P07900 1/20 0.54
MAPT P10636 1/20 0.54
IDO1 P14902 1/20 0.54
HPGD P15428 1/20 0.54
MAOA P21397 1/20 0.54
CNR1 P21554 1/20 0.54
HTR2A P28223 1/20 0.54
MAPK1 P28482 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Irtemazole SCHEMBL7453697 0.91 CYP26A1 (0.57) CYP26A1CYP19A1CYP17A1CYP3A4MEN1
Irtemazole SCHEMBL9717354 0.91 CYP26A1 (0.57) CYP26A1CYP19A1CYP17A1CYP3A4MEN1
SCHEMBL12336821 0.82 CYP19A1 (0.52) CYP26A1CYP19A1CYP17A1CYP3A4MEN1
SCHEMBL9664150 0.80 CYP19A1 (0.51) CYP26A1CYP19A1CYP17A1CYP3A4MEN1
SCHEMBL9663550 0.80 CYP19A1 (0.65) CYP26A1CYP19A1CYP17A1CYP3A4MEN1
Water SCHEMBL9728138 0.79 CYP19A1 (0.61) CYP26A1CYP19A1CYP17A1CYP3A4MEN1
SCHEMBL12337074 0.77 CYP19A1 (0.48) CYP26A1CYP19A1CYP17A1CYP3A4CNR1
SCHEMBL9190606 0.77 CYP26A1 (0.53) CYP26A1CYP19A1CYP17A1CYP3A4MEN1
SCHEMBL9195873 0.77 CYP19A1 (0.58) CYP26A1CYP19A1CYP17A1CYP3A4MEN1
SCHEMBL9663750 0.77 CYP26A1 (0.55) CYP26A1CYP19A1CYP17A1CYP3A4MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 257 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9016221-B2 Surface topographies for non-toxic bioadhesion control UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2015-04-28 US claimed
EP-2064246-B1 USE OF IL-23 ANTAGONISTS FOR TREATMENT OF INFECTION MERCK SHARP & DOHME (US) 2013-05-22 EP claimed
US-8268352-B2 Modified release composition for highly soluble drugs TORRENT PHARMACEUTICALS LIMITED (IN) 2012-09-18 US claimed
US-8263125-B2 Dosage form for high dose-high solubility active ingredients that provides for immediate release and modified release of the active ingredients TORRENT PHARMACEUTICALS LIMITED (IN) 2012-09-11 US claimed
US-7795302-B2 Use of compositions for treating rosacea THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2010-09-14 US claimed
US-20100226943-A1 SURFACE TOPOGRAPHIES FOR NON-TOXIC BIOADHESION CONTROL UNIVERSITY OF FLORIDA (US) 2010-09-09 US claimed
CN-101330905-A Freeze-drying process and products obtained thereby SCIDOSE LLC (US) 2008-12-24 CN claimed
EP-1954244-A1 LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY Scidose, Llc (US) 2008-08-13 EP claimed
WO-2007061529-A1 LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY SCIDOSE LLC. (US) 2007-05-31 WO claimed
US-20070116729-A1 Lyophilization process and products obtained thereby SCIDOSE LLC 2007-05-24 US claimed
US-20060024365-A1 Novel dosage form VAYA NAVIN 2006-02-02 US claimed
US-20060018933-A1 Novel drug delivery system TORRENT PHARMACEUTICALS LIMITED (IN) 2006-01-26 US claimed
US-20060018934-A1 Novel drug delivery system TORRENT PHARMACEUTICALS LIMITED (IN) 2006-01-26 US claimed
EP-1385496-A2 USE OF COMPOSITIONS FOR TREATING ROSACEA THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2004-02-04 EP claimed
WO-2003094969-A1 METHODS AND COMPOSITIONS FOR TREATING TINEA VERSICOLOR USING COMBINATIONS OF RETINOIDS AND CERTAIN ANTIFUNGALS THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2003-11-20 WO claimed
US-20030212077-A1 Methods and compositions for treating tinea versicolor using combinations of retinoids and certain antifungals BIRNBAUM JAY E (US) 2003-11-13 US claimed
US-20020183399-A1 Method and compositions for treating rosacea REGENTS OF THE UNIVERSITY OF MICHIGAN, THE 2002-12-05 US claimed
WO-2002089743-A2 USE OF COMPOSITIONS FOR TREATING ROSACEA THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2002-11-14 WO claimed
WO-2001034142-A1 A METHOD OF TREATING AND LIGHTENING HYPERPIGMENTATION IN BLACK SKIN WITH A RETINOID THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2001-05-17 WO claimed
US-6017960-A DISCOLORING OR BLEACHING THE SKIN REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2000-01-25 US claimed